Tumor-Agnostic Therapies: Is This a Paradigm Shift in Cancer Care?
Diagnosis and Treatment, Clinical Research, Research, Novel Treatments, Medical Community Our MBClife Diagnosis and Treatment, Clinical Research, Research, Novel Treatments, Medical Community Our MBClife

Tumor-Agnostic Therapies: Is This a Paradigm Shift in Cancer Care?

Do tumor-agnostic therapies represent a radical shift in oncology? Join us on this 1st part of a 2-part series as Dr. Joshua Drago of MSKCC answers this question and points out the advantages as well as the treatment limitations of agnostic therapeutics.

Read More
Report Back From ASCO 2024: What’s the Latest in HR+ MBC?
Living with MBC, Diagnosis and Treatment, Clinical Research, Research, ASCO Our MBClife Living with MBC, Diagnosis and Treatment, Clinical Research, Research, ASCO Our MBClife

Report Back From ASCO 2024: What’s the Latest in HR+ MBC?

We are thrilled to present an audio version of SHARE Cancer Support’s webinar “Report Back from ASCO 2024: Latest Updates on HR+ Metastatic Breast Cancer (MBC)”.

This episode is an in-depth report from the ASCO 2024 Annual Meeting, featuring the latest advancements and research in HR+ MBC. Hear from Dr. Kevin Kalinsky as we dive into the findings from the DESTINY-Breast06 and postMONARCH trials, exploring their implications and potential impact on treatment strategies.

Read More
MBC Matters: Understanding Blood Test Results
Living with MBC, Diagnosis and Treatment, MBC Imaging and Profiling, Medical Community Our MBClife Living with MBC, Diagnosis and Treatment, MBC Imaging and Profiling, Medical Community Our MBClife

MBC Matters: Understanding Blood Test Results

Blood tests are an essential part of our cancer care. However, interpreting them can often feel like deciphering a foreign language.

Joining us today is Dr. Alfredo Torres and we’ll break down the common types of blood tests, explain what the numbers mean, and discuss how these results impact your treatment plan.

Read More